Literature DB >> 29850193

Pan-endoscopic tumor length as the marker to predict response to neoadjuvant therapy for ESCC warrants additional investigation.

Yu-Feng Deng1, Tian-Zhu Yuan1.   

Abstract

Entities:  

Year:  2018        PMID： 29850193      PMCID： PMC5949427          DOI： 10.21037/jtd.2018.03.144

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  4 in total

Review 1.  Update on the paris classification of superficial neoplastic lesions in the digestive tract.

Authors: 
Journal:  Endoscopy       Date:  2005-06       Impact factor: 10.093

2.  Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis.

Authors:  Katrin M Sjoquist; Bryan H Burmeister; B Mark Smithers; John R Zalcberg; R John Simes; Andrew Barbour; Val Gebski
Journal:  Lancet Oncol       Date:  2011-06-16       Impact factor: 41.316

3.  Prognostic role of initial pan-endoscopic tumor length at diagnosis in operable esophageal squamous cell carcinoma undergoing esophagectomy with or without neoadjuvant concurrent chemoradiotherapy.

Authors:  Chen-Sung Lin; Chao-Yu Liu; Chih-Tao Cheng; Yu-Chen Tsai; Lun-Wei Chiou; Ming-Yuan Lee; Chia-Chuan Liu; Chih-Hsun Shih
Journal:  J Thorac Dis       Date:  2017-09       Impact factor: 2.895

Review 4.  Update on Neoadjuvant Regimens for Patients with Operable Oesophageal/Gastrooesophageal Junction Adenocarcinomas and Squamous Cell Carcinomas.

Authors:  Samantha J Cox; Sean M O'Cathail; Bernadette Coles; Tom Crosby; Somnath Mukherjee
Journal:  Curr Oncol Rep       Date:  2017-01       Impact factor: 5.075
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.